Temple R - Search Results

1

Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran.

Beasley BN, Unger EF, Temple R. Beasley BN, et al. Among authors: temple r. N Engl J Med. 2011 May 12;364(19):1788-90. doi: 10.1056/NEJMp1103050. Epub 2011 Apr 13. N Engl J Med. 2011. PMID: 21488759 Free article. No abstract available.

2

Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.

Merkatz RB, Temple R, Subel S, Feiden K, Kessler DA. Merkatz RB, et al. Among authors: temple r. N Engl J Med. 1993 Jul 22;329(4):292-6. doi: 10.1056/NEJM199307223290429. N Engl J Med. 1993. PMID: 8305004 Free article. No abstract available.

3

Erythropoiesis-stimulating agents--time for a reevaluation.

Unger EF, Thompson AM, Blank MJ, Temple R. Unger EF, et al. Among authors: temple r. N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6. N Engl J Med. 2010. PMID: 20054037 No abstract available.

4

New FDA regulation to improve safety reporting in clinical trials.

Sherman RB, Woodcock J, Norden J, Grandinetti C, Temple RJ. Sherman RB, et al. N Engl J Med. 2011 Jul 7;365(1):3-5. doi: 10.1056/NEJMp1103464. Epub 2011 Jun 8. N Engl J Med. 2011. PMID: 21651388 Free article. No abstract available.

5

Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.

Laughren TP, Gobburu J, Temple RJ, Unger EF, Bhattaram A, Dinh PV, Fossom L, Hung HM, Klimek V, Lee JE, Levin RL, Lindberg CY, Mathis M, Rosloff BN, Wang SJ, Wang Y, Yang P, Yu B, Zhang H, Zhang L, Zineh I. Laughren TP, et al. J Clin Psychiatry. 2011 Sep;72(9):1166-73. doi: 10.4088/JCP.11r06984. J Clin Psychiatry. 2011. PMID: 21951984 Review.

6

Zolpidem and driving impairment--identifying persons at risk.

Farkas RH, Unger EF, Temple R. Farkas RH, et al. Among authors: temple r. N Engl J Med. 2013 Aug 22;369(8):689-91. doi: 10.1056/NEJMp1307972. Epub 2013 Aug 7. N Engl J Med. 2013. PMID: 23923991 Free article. No abstract available.

7

Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration.

Borges S, Chen YF, Laughren TP, Temple R, Patel HD, David PA, Mathis M, Unger E, Yang P, Khin NA. Borges S, et al. Among authors: temple r. J Clin Psychiatry. 2014 Mar;75(3):205-14. doi: 10.4088/JCP.13r08722. J Clin Psychiatry. 2014. PMID: 24717376 Review.

8

Evaluating Ebola therapies--the case for RCTs.

Cox E, Borio L, Temple R. Cox E, et al. Among authors: temple r. N Engl J Med. 2014 Dec 18;371(25):2350-1. doi: 10.1056/NEJMp1414145. Epub 2014 Dec 3. N Engl J Med. 2014. PMID: 25470568 Free article. No abstract available.

9

The US Food and Drug Administration's perspective on the new antidepressant vortioxetine.

Zhang J, Mathis MV, Sellers JW, Kordzakhia G, Jackson AJ, Dow A, Yang P, Fossom L, Zhu H, Patel H, Unger EF, Temple RJ. Zhang J, et al. J Clin Psychiatry. 2015 Jan;76(1):8-14. doi: 10.4088/JCP.14r09164. J Clin Psychiatry. 2015. PMID: 25562777

10

Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trials.

Khin NA, Kronstein PD, Yang P, Ishida E, Hung HM, Mathis MV, Unger EF, Temple RJ. Khin NA, et al. J Clin Psychiatry. 2015 Aug;76(8):1060-3. doi: 10.4088/JCP.14cs09700. J Clin Psychiatry. 2015. PMID: 26214346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters